Search alternatives:
developments » development (Expand Search)
Showing 5,101 - 5,120 results of 5,343 for search 'registration developments', query time: 0.17s Refine Results
  1. 5101

    HiSNAP trial—a multicentre, randomised, open-label, blinded end point, safety and efficacy trial of conventional (300 mg/kg) versus higher doses of acetylcysteine (450 mg/kg and 60... by Alasdair Gray, David M Wood, Jacqueline James, Keith Boath, Rajendra Raman, Matt Reed, Rachel O’Brien, Alison Grant, Sharon Tuck, Liza Keating, Craig Davidson, Christopher J Weir, Jonathan Carter, Stephen Lynch, James W Dear, Michael Eddleston, Lyle Moncur, Julia Grahamslaw, Katherine Oatey, Marianne Gillings, Lynsey Milne, Natalie Homer, Caroline Blackstock, Philippa Wright, Christopher Humphries, Alan Timmins, Laura Muir, Ruben Thanacoody, Ellise Clarke, Heather Robertson, Anna Miell, Chloe Haigh, Luisa Padovani, Karen Gray, Sandra Pirie, Christina Coventry, Amy Armstrong, Sian Irvine, Oliver Carlill, Donna Clark, Fraser Craig, Angela Crawford, Carlyn Davie, Judith Flemming, Marie-Claire Harris, Katy Letham, Malgorzata Litwin, Fiona McCurrach, Shona McDonald, Fraser McFadyen, Hazel Milligan, Victoria Minnis, Gillian Pickering, Rebecca Rielly, Emma-Beth Wilson, Lisa-Marie Butt, Kathleen Scullion, Claire Cheyne, Angela McGeough, Nikki McLaughlin, Fern Purdie, Sandee Beattie, Anna Borkowska, Katie Hamilton, Keith Jacques, Jeronimo Martin Ramirez, Vasilika Ntoko, Surinder Pandhor, Janine Ramsey, Maria Simpson

    Published 2025-03-01
    “…The study will first test the primary outcome on the HiSNAP Group 2 against Standard NAC; only if that is significant will HiSNAP Group 1 be tested against Standard NAC.Ethics and dissemination The HiSNAP trial has been approved by the East Midlands (Derby) Research Ethics Committee (reference 23/EM/0129), NHS Lothian Research and Development Department, and the MHRA. Results will be disseminated by peer-reviewed publication, conferences and linked on isrctn.com.Trial registration number ISRCTN17516192.…”
    Get full text
    Article
  2. 5102

    Digital delivery of behavioural activation therapy to overcome depression and facilitate social and economic transitions of adolescents in South Africa (the DoBAt study): protocol... by Stephen Tollman, Kathleen Kahn, F Xavier Gómez-Olivé, Crick Lund, Alan Stein, Heather A O'Mahen, Eustasius Musenge, Sarah-Jayne Blakemore, Alastair van Heerden, Tholene Sodi, Bianca D Moffett, Julia R Pozuelo, Michelle Craske, Kate Orkin, Emma J Kilford, Mahreen Mahmud, Meghan Davis, Zamakhanya Makhanya, Tlangelani Baloyi, Daniel Mahlangu, Gabriele Chierchia, Sophie L Fielmann, Imraan Valodia

    Published 2022-12-01
    “…Secondary objectives are to pilot a range of cognitive, mental health, risky behaviour and socioeconomic measures; and to collect descriptive data on the feasibility of trial procedures to inform the development of a further larger trial.Ethics and dissemination This study has been approved by the University of the Witwatersrand Human Research Ethics Committee (MED20-05-011) and the Oxford Tropical Research Ethics Committee (OxTREC 34-20). …”
    Get full text
    Article
  3. 5103

    Addressing Hypertension and Diabetes through Community-Engaged Systems (ANDES) in Puno, Peru: rationale and study protocol for a hybrid type 2 effectiveness and implementation rand... by Lindsay J. Underhill, Kendra N. Williams, Lucy Cordova-Ascona, Karina Campos, Lisa de las Fuentes, Mark D. Huffman, Joel Gittelsohn, Kenneth B. Schechtman, Zoila Vela-Clavo, Carla Tarazona-Meza, Laura K. Beres, Parker K. Acevedo, Abigail Barker, Nishadi Rajapakse, Makeda Williams, Veronica Tonwe, Aaloke Mody, Raquel Hurtado, Juan Carlos Mendoza, Gonzalo Cuentas, Elvin H. Geng, William Checkley, Victor G. Dávila-Román, Stella M. Hartinger-Peña

    Published 2024-11-01
    “…Furthermore, by addressing both hypertension and diabetes, the ANDES strategy supports integrated care approaches advocated by the WHO HEARTS technical package, ultimately enhancing health outcomes and reducing morbidity and mortality in the region. Trial registration ClinicalTrials.gov, ID: NCT05524987 , Addressing Hypertension and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study), prospectively registered on September 1, 2021.…”
    Get full text
    Article
  4. 5104
  5. 5105
  6. 5106

    Assessment of ovarian dysfunction induced by environmental toxins: a systematic review by Lu An, Yali Huang, Yunkai Wang, Shuting Shen, Xuexing Luo, Xiaoyan Liang, Xiaoyan Liang, Liming Lu, Chunzhi Tang, Jinglin Lin, Jinglin Lin, Ting Su, Ting Su, Meiqi Zhan, Meiqi Zhan, Dongying Wang, Dongying Wang, Jue Wang, Jue Wang, Xin Lai, Xin Lai, Yu Li, Yu Li

    Published 2025-07-01
    “…The findings underscore the importance of regular ovarian health monitoring, especially for women at higher risk due to occupational or environmental factors.Systematic review registrationPROSPERO CRD42024567744 (accessible at https://www.crd.york.ac.uk/prospero/display_record.php?…”
    Get full text
    Article
  7. 5107
  8. 5108

    Early Life Exposure in Mexico to ENvironmental Toxicants (ELEMENT) Project by Lu Tang, Manish Arora, Wei Perng, Marcela Tamayo-Ortiz, Brisa N Sánchez, Alejandra Cantoral, John D Meeker, Dana C Dolinoy, Elizabeth F Roberts, Esperanza Angeles Martinez-Mier, Hector Lamadrid-Figueroa, Peter X K Song, Adrienne S Ettinger, Robert Wright, Lourdes Schnaas, Deborah J Watkins, Jaclyn M Goodrich, Robin C Garcia, Maritsa Solano-Gonzalez, Luis F Bautista-Arredondo, Adriana Mercado-Garcia, Howard Hu, Mauricio Hernandez-Avila, Martha Maria Tellez-Rojo, Karen E Peterson

    Published 2019-08-01
    “…Research has also expanded to include findings published on other toxicants such as those associated with personal care products and plastics (eg, phthalates, bisphenol A), other metals (eg, mercury, manganese, cadmium), pesticides (organophosphates) and fluoride; other biomarkers (eg, toxicant levels in plasma, hair and teeth); other outcomes (eg, sexual maturation, metabolic syndrome, dental caries); and identification of novel mechanisms via epigenetic and metabolomics profiling.Future plans As the ELEMENT mothers and children age, we plan to (1) continue studying the long-term consequences of toxicant exposure during the perinatal period on adolescent and young adult outcomes as well as outcomes related to the original ELEMENT mothers, such as their metabolic and bone health during perimenopause; and (2) follow the third generation of participants (children of the children) to study intergenerational effects of in utero exposures.Trial registration number NCT00558623.…”
    Get full text
    Article
  9. 5109
  10. 5110
  11. 5111
  12. 5112

    Understanding the association of intrapancreatic fat deposition with adiposity and components of metabolic syndrome in children and adolescents: a systematic review and meta-analys... by Claudia Izquierdo Rodríguez, Cristina Cadenas-Sanchez, José L. Santos, Jonatan R. Ruiz, María Medrano, Vicente Martínez-Vizcaíno, Michael I. Goran, Idoia Labayen

    Published 2025-05-01
    “…Longitudinal studies are necessary to understand the temporal dynamics of these associations and to determine the long-term impact of intrapancreatic fat deposition on the risk of developing type 2 diabetes and cardiovascular diseases. …”
    Get full text
    Article
  13. 5113

    Facilitators, barriers, and guidance to successful implementation of multidisciplinary transitional care interventions: A qualitative systematic review using the consolidated frame... by Romain Collet, Juul van Grootel, Marike van der Leeden, Marike van der Schaaf, Johanna van Dongen, Suzanne Wiertsema, Edwin Geleijn, Mel Major, Raymond Ostelo

    Published 2025-06-01
    “…Further research should identify effective implementation strategies, considering the pre-, post-discharge, and general factors identified. Registration: The protocol was registered in PROSPERO (CRD42023421423). …”
    Get full text
    Article
  14. 5114

    HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer by Jianhua Zhan, Jinhui Xue, Lin Wu, Zhiye Zhang, Qiming Wang, Yuxiang Ma, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Wenfeng Fang, Yang Zhang, Qianwen Liu, Wen Xu, Yan Yang, Zhenming Chen, Baili Song, Danni Sun, Xia Sun, Peng Gao, Hongyun Zhao, Li Zhang

    Published 2025-06-01
    “…Abstract Background The C797S mutation is one of the most common mechanisms of acquired resistance to third generation EGFR TKIs, yet no approved therapies have been available to target it. Here we developed a novel selective EGFR C797S inhibitor, HS-10375, and report the results of pre-clinical research and the first-in-human phase 1 trial. …”
    Get full text
    Article
  15. 5115
  16. 5116
  17. 5117
  18. 5118

    Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysis by Gordon Guyatt, Arnav Agarwal, Thomas Agoritsas, Haoming Tian, Sheyu Li, Chang Xu, Ping Fu, Qingyang Shi, Xiaoxi Zeng, Per Olav Vandvik, Xinyu Zou, Yunhe Mao, Qinbo Yang, Xianghang Luo, Belen Ponte

    Published 2024-08-01
    “…Absolute benefits and harms stratified by risk and associated with SGLT-2 inhibitors should inform individual decision making at the patient level.Systematic review registration PROSPERO CRD42022325483.…”
    Get full text
    Article
  19. 5119
  20. 5120